SpyGlass Pharma, Inc. Common Stock (SGP)

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

SpyGlass Pharma, Inc. Common Stock (SGP) is listed on Nasdaq, where it has traded since February 6, 2026.

Listed On
Nasdaq
Listed Since
February 6, 2026
Employees
65
Market Cap
$1.1B

About SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 50 institutions reported holding SGP, with 26.1 million shares worth $581.1 million in aggregate. The largest reported holder was RA Capital Management, with 8.0 million shares worth $178.6 million. Of the 5 largest holders listed below, 1 added shares and 4 held their positions unchanged during the quarter.

InstitutionSharesValueQuarter change
RA Capital Management8,021,117$179MUnchanged
Nea Management Company7,392,301$165MUnchanged
Sands Capital Ventures2,500,012$56MUnchanged
Samsara Biocapital2,109,953$47MUnchanged
BlackRock711,712$16MAdded 391.72%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is SGP?

SpyGlass Pharma, Inc. Common Stock (SGP) is listed on Nasdaq, where it has traded since February 6, 2026.

Who are the largest institutional holders of SGP?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of SGP were RA Capital Management, Nea Management Company and Sands Capital Ventures.

How many institutions own SGP?

50 institutions reported a position in SGP for the quarter ended June 30, 2026, worth $581.1 million in total.

Did institutions buy or sell SGP last quarter?

Of the 5 largest reported holders, 1 added shares and 4 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for SGP.

Every reported institutional holder, plus insider and congressional trades in SGP, on SentiSense.